Skip to content
HowShorted

Altimmune, Inc. short interest in 2022

In 2022, Altimmune, Inc.'s disclosed short interest ran from 11.53% of shares outstanding on 14 Jan 2022 to 15.43% on 30 Dec 2022, a change of +3.90 percentage points. The year's high was 15.87% on 30 Sep 2022 and its low 6.11% on 31 Mar 2022, averaging 11.42% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.71 days on 14 Jan 2022. Full history: Altimmune, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Altimmune, Inc. in 2022

2022 in figures

Start of year
11.53% (14 Jan 2022)
End of year
15.43% (30 Dec 2022)
Change
+3.90 pp
High
15.87% (30 Sep 2022)
Low
6.11% (31 Mar 2022)
Average
11.42%
Highest days to cover
7.71 (14 Jan 2022)
SEC filings marked
8

Every report in 2022

Altimmune, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202211.53%7.71
31 Jan 20228.49%4.12
15 Feb 20229.06%5.45
28 Feb 20229.92%5.53
15 Mar 20229.58%4.8910-K filed, results (8-K)
31 Mar 20226.11%1.91
14 Apr 20226.56%4.13
29 Apr 20226.99%5.01
13 May 20228.92%4.8110-Q filed, results (8-K)
31 May 20229.12%6.66
15 Jun 202214.25%2.59
30 Jun 202213.81%2.29
15 Jul 202210.18%3.67
29 Jul 202211.25%4.63
15 Aug 202210.01%2.2010-Q filed, results (8-K)
31 Aug 202212.69%4.61
15 Sep 202213.93%1.02
30 Sep 202215.87%2.76
14 Oct 202214.53%5.25
31 Oct 202214.76%6.82
15 Nov 202214.82%5.7010-Q filed, results (8-K)
30 Nov 202213.34%7.30
15 Dec 202212.90%6.16
30 Dec 202215.43%2.69

See also: Altimmune, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.